Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | ARG1 | P05089 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3450045 | 1.00 | CYP2D6 (0.48) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL5861606 | 1.00 | CYP2D6 (0.48) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL683739 | 1.00 | CYP2D6 (0.48) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL683685 | 0.86 | CHRM2 (0.36) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL7208477 | 0.83 | CHRM2 (0.34) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL7208474 | 0.83 | CHRM2 (0.34) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL16397618 | 0.82 | CYP2D6 (0.43) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL16397424 | 0.82 | CYP2D6 (0.43) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL12896178 | 0.82 | CYP2D6 (0.43) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL16397280 | 0.82 | CYP2D6 (0.43) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030280-B2 | Process for producing optically active β-trifluoromethyl-β-hydroxycarbonyl compound | CENTRAL GLASS COMPANY, LIMITED (JP) | 2006-04-18 | — | — | US | claimed |
| US-20050119507-A1 | Process for producing optically active beta-trifluoromethyl-beta-hydroxycarbonyl compound | CENTRAL GLASS COMPANY, LIMITED (JP) | 2005-06-02 | — | — | US | claimed |
| US-5494898-A | DIQUATERNARY TRIPEPTIDES | OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC. (US) | 1996-02-27 | — | — | US | claimed |
| US-20240309406-A1 | PROCESS FOR PREPARING RASPBERRY KETONE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-09-19 | — | — | US | disclosed |
| US-20230416182-A1 | PROCESS FOR PREPARING FRAMBIONE | RHODIA OPERATIONS (FR) | 2023-12-28 | — | — | US | disclosed |
| EP-4259812-A1 | METHOD FOR THE PREPARATION OF FRAMBINONE | SPECIALTY OPERATIONS FRANCE (FR) | 2023-10-18 | — | — | EP | disclosed |
| EP-4255879-A1 | METHOD FOR PRODUCING FRAMBINONE | RHODIA OPERATIONS (FR) | 2023-10-11 | — | — | EP | disclosed |
| CN-116615407-A | Method for producing raspberry ketone | 罗地亚经营管理公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116547385-A | Method for producing raspberry ketone | 罗地亚经营管理公司 | 2023-08-04 | — | — | CN | disclosed |
| WO-2022129012-A1 | METHOD FOR THE PREPARATION OF FRAMBINONE | RHODIA OPERATIONS (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022117670-A1 | METHOD FOR PRODUCING FRAMBINONE | RHODIA OPERATIONS (FR) | 2022-06-09 | — | — | WO | disclosed |
| US-5494898-A | DIQUATERNARY TRIPEPTIDES | OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC. (US) | 1996-02-27 | — | — | US | disclosed |
| US-5494898-A | DIQUATERNARY TRIPEPTIDES | OHMEDA PHARMACEUTICAL PRODUCTS DIVISION INC. (US) | 1996-02-27 | — | — | US | disclosed |
| WO-1995033762-A1 | PERFLUOROALKYL KETONE INHIBITORS OF ELASTASE AND PROCESSES FOR MAKING THE SAME | MERRELL PHARMACEUTICALS INC. (US) | 1995-12-14 | — | — | WO | disclosed |
| EP-0647449-A1 | Sustained-release preparation of anti-endothelin substance | Takeda Chemical Industries, Ltd. (JP) | 1995-04-12 | — | — | EP | disclosed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | disclosed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | disclosed |
| EP-0498940-A2 | Peptide amides and amide dimers | BOC Health Care, Inc. (US) | 1992-08-19 | — | — | EP | disclosed |
| EP-0498941-A2 | Peptide skeletal muscle relaxants | BOC Health Care, Inc. (US) | 1992-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416182-A1 | PROCESS FOR PREPARING FRAMBIONE | GRHPR, FDPS, FPGS | CYP2D6 1858/4885CYP1A2 1274/4885ALOX15 475/4885 |
| US-20050119507-A1 | Process for producing optically active beta-trifluoromethyl-beta-hydroxycarbonyl compound | CYP8B1, HCCS, DHPS | CYP2D6 490/4885CYP1A2 251/4885ALOX15 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.